Immunochemical and Mass-Spectrometry–Based Serum Hepcidin Assays for Iron Metabolism Disorders
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hepcidin is an iron-regulatory peptide hormone that consists of 3 isoforms: bioactive hepcidin-25, and inactive hepcidin-22 and hepcidin-20. Hepcidin is instrumental in the diagnosis and monitoring of iron metabolism disorders, but reliable methods for its quantification in serum are sparse, as is knowledge of their relative analytical strengths and clinical utility. METHODS: We developed a competitive (c)-ELISA and an immunocapture TOF mass-spectrometry (IC-TOF-MS) assay. Exploiting these 2 methods and our previously described weak cation exchange (WCX)-TOF-MS assay, we measured serum hepcidin concentrations in 186 patients with various disorders of iron metabolism and in 23 healthy controls. RESULTS: We found that (a) the relative differences in median hepcidin concentrations in various diseases to be similar, although the absolute concentrations measured with c-ELISA and WCX-TOF-MS differed; (b) hepcidin isoforms contributed to differences in hepcidin concentrations between methods, which were most prominent in patients with chronic kidney disease; and (c) hepcidin concentrations measured by both the c-ELISA and IC-TOF-MS correlated with ferritin concentrations <60 μg/L, and were suitable for distinguishing between iron deficiency anemia (IDA) and the combination of IDA and anemia of chronic disease. CONCLUSIONS: c-ELISA is the method of choice for the large-scale quantification of serum hepcidin concentrations, because of its low limit of detection, low cost, and high-throughput. Because of its specificity for bioactive hepcidin-25, WCX-TOF-MS can be regarded as a valuable special-purpose assay for disorders with variable concentrations of hepcidin isoforms, such as chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Immunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
Forging a field: the golden age of iron biology.
Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623
The Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation
De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434
Hunter, H. N., Fulton, D. B., Ganz, T., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205305200 · Cited by 400
de Mast, Q., Nadjm, B., Reyburn, H., Kemna, E. H. J. M., Amos, B., Laarakkers, C. M. M., Silalye, S., Verhoef, H., Sauerwein, R. W., Swinkels, D. W., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/595790 · Cited by 89
Self-citationTheurl, I., Finkenstedt, A., Schroll, A., Nairz, M., Sonnweber, T., Bellmann‐Weiler, R., Theurl, M., Seifert, M., Wroblewski, V. J., Murphy, A. T., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07961.x · Cited by 72
Cited by
Moretti, D., Goede, J. S., Zeder, C., Jiskra, M., Chatzinakou, V., Tjalsma, H., Melse-Boonstra, A., Brittenham, G., Swinkels, D. W., & Zimmermann, M. B. (2015) · Blood · doi:10.1182/blood-2015-05-642223 · Cited by 547
Self-citationStoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435
Self-citationHepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417
Self-citationSerum hepcidin: reference ranges and biochemical correlates in the general population
Galesloot, T. E., Vermeulen, S. H., Geurts-Moespot, A. J., Klaver, S. M., Kroot, J. J., van Tienoven, D., Wetzels, J. F. M., Kiemeney, L. A. L. M., Sweep, F. C., den Heijer, M., et al. (2011) · Blood · doi:10.1182/blood-2011-02-337907 · Cited by 303
Self-citationGrote Beverborg, N., Klip, I. T., Meijers, W. C., Voors, A. A., Vegter, E. L., van der Wal, H. H., Swinkels, D. W., van Pelt, J., Mulder, A. B., Bulstra, S. K., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004519 · Cited by 278
Self-citationHepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
“HPLC/UPLC MS/MS (87;88) c-ELISA (13;29;98;99) (Bachem) Q-TOF LC-MS (92)”
Self-citationLC–MS/MS for protein and peptide quantification in clinical chemistry
Rauh, M. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.09.030 · Cited by 171
Wouters, H. J. C. M., van der Klauw, M. M., de Witte, T., Stauder, R., Swinkels, D. W., Wolffenbuttel, B. H. R., & Huls, G. (2019) · Haematologica · doi:10.3324/haematol.2018.195552 · Cited by 157
Tisi, M. C., Bozzoli, V., Giachelia, M., Massini, G., Ricerca, B. M., Maiolo, E., D’Alo’, F., Larocca, L. M., Piciocchi, A., Tjalsma, H., et al. (2014) · Leukemia & Lymphoma · doi:10.3109/10428194.2013.802314 · Cited by 59
Self-citationBadenhorst, C. E., Dawson, B., Cox, G. R., Laarakkers, C. M., Swinkels, D. W., & Peeling, P. (2015) · European Journal of Applied Physiology · doi:10.1007/s00421-015-3252-3 · Cited by 57
Self-citationSerum Hepcidin in Inflammatory Bowel Diseases: Biological and Clinical Significance
Bergamaschi, G., Di Sabatino, A., Albertini, R., Costanzo, F., Guerci, M., Masotti, M., Pasini, A., Massari, A., Campostrini, N., Corbella, M., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829a6e43 · Cited by 56
Chronic Adherence to a Ketogenic Diet Modifies Iron Metabolism in Elite Athletes
MCKAY, A. K. A., PEELING, P., PYNE, D. B., WELVAERT, M., TEE, N., LECKEY, J. J., SHARMA, A. P., ROSS, M. L. R., GARVICAN-LEWIS, L. A., SWINKELS, D. W., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001816 · Cited by 53
Self-citationFactors influencing the post-exercise hepcidin-25 response in elite athletes
Peeling, P., McKay, A. K. A., Pyne, D. B., Guelfi, K. J., McCormick, R. H., Laarakkers, C. M., Swinkels, D. W., Garvican-Lewis, L. A., Ross, M. L. R., Sharma, A. P., et al. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3611-3 · Cited by 49
Self-citationShanmugam, N. K. N., Trebicka, E., Fu, L.-L., Shi, H. N., & Cherayil, B. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400278 · Cited by 49
Jonker, F. A. M., Calis, J. C. J., Phiri, K., Kraaijenhagen, R. J., Brabin, B. J., Faragher, B., Wiegerinck, E. T., Tjalsma, H., Swinkels, D. W., & Boele van Hensbroek, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078964 · Cited by 42
“Hepcidin assessments were measured by a combination of weak cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF-MS) [24].”
MethodHematologic parameters predicting a response to oral iron therapy in chronic inflammation
van Santen, S., de Mast, Q., Oosting, J. D., van Ede, A., Swinkels, D. W., & van der Ven, A. J. A. M. (2014) · Haematologica · doi:10.3324/haematol.2014.106799 · Cited by 44
Wisaksana, R., de Mast, Q., Alisjahbana, B., Jusuf, H., Sudjana, P., Indrati, A. R., Sumantri, R., Swinkels, D., van Crevel, R., & van der Ven, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079904 · Cited by 35
“) was used for quantification [22,23].”
Self-citationMcKay, A. K. A., Peeling, P., Pyne, D. B., Welvaert, M., Tee, N., Leckey, J. J., Sharma, A. P., Ross, M. L. R., Garvican-Lewis, L. A., van Swelm, R. P. L., et al. (2019) · Journal of Science and Medicine in Sport · doi:10.1016/j.jsams.2018.12.015 · Cited by 26
Self-citationSeven days of high carbohydrate ingestion does not attenuate post-exercise IL-6 and hepcidin levels
Badenhorst, C. E., Dawson, B., Cox, G. R., Sim, M., Laarakkers, C. M., Swinkels, D. W., & Peeling, P. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3426-7 · Cited by 20
“The reference levels for the WCX-TOF MS method are derived from those of our ELISA method (Galesloot et al. 2011), based on the regression line between the ELISA and WCX-TOF MS results obtained for the same samples from patients without hepcidin isoforms (Kroot et al. 2010).”
Self-citation
Metadata
- Authors
- Kroot, J. J., Laarakkers, C. M., Geurts-Moespot, A. J., Grebenchtchikov, N., Pickkers, P., van Ede, A. E., Peters, H. P., van Dongen-Lases, E., Wetzels, J. F., Sweep, F. C., Tjalsma, H., & Swinkels, D. W.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-01
- Volume
- 56
- Issue
- 10
- Pages
- 1570-1579
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2144753011
- Cited by
- 196
- References
- 8
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.